← Back to Search

Anti-obesity medication

Phentermine - Topiramate Extended Release group for Obesity

Phase 4
Waitlist Available
Led By Andres Acosta, MD, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is testing whether a weight loss medication is better than a placebo, with participants using activity trackers and digital wellness devices to help them.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Body Weight Change
Change in Calories
Change in SF-12 Mental Score (Health-related Quality Quality of Life)
+4 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Phentermine - Topiramate Extended Release groupActive Control2 Interventions
Group II: Placebo GroupPlacebo Group2 Interventions

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,704 Total Patients Enrolled
84 Trials studying Obesity
14,643 Patients Enrolled for Obesity
Andres Acosta, MD, PhDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
51 Total Patients Enrolled
1 Trials studying Obesity
36 Patients Enrolled for Obesity

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker
Andres J. Acosta, M.D., Ph.D. 2020. "Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04408586.
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top